SAJJADI, ELHAM
SAJJADI, ELHAM
Dipartimento di Oncologia ed Emato-Oncologia
The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property
2025 A. Corradi, G. Bonizzi, E. Sajjadi, F. Pavan, M. Fumagalli, L.O. Molendini, M. Monturano, C. Cassi, C.R. Musico, L. Leoni, C. Frascarelli, O. Pala, E.G. Rocco, A. Albini, R. Orecchia, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
THE IMMUNE MOLECULAR LANDSCAPE OF BREAST CANCER DURING PREGNANCY
2024 E. Sajjadi
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
2024 G. Corso, E. Marino, C. Zanzottera, C. Oliveira, L. Bernard, D. Macis, J. Figueiredo, J. Pereira, P. Carneiro, G. Massari, M. Barberis, A.M. De Scalzi, S.V. Taormina, E. Sajjadi, C. Sangalli, S. Gandini, O. D'Ecclesiis, C.M. Trovato, A. Rotili, F. Pesapane, L. Nicosia, C. La Vecchia, V. Galimberti, E. Guerini-Rocco, B. Bonanni, P. Veronesi
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
2023 E. Sajjadi, K. Venetis, M. Ivanova, M. Noale, C. Blundo, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, P. Veronesi, V.E. Galimberti, G. Viale, F.A. Peccatori, N. Fusco, E. Guerini-Rocco
The molecular landscape of breast mucoepidermoid carcinoma
2023 K. Venetis, E. Sajjadi, M. Ivanova, S. Andaloro, S. Pessina, C. Zanetti, A. Ranghiero, G. Citelli, C. Rossi, M. Lucioni, U. Malapelle, F. Pagni, M. Barberis, E. Guerini-Rocco, G. Viale, N. Fusco
Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”
2023 E. Sajjadi, K. Venetis, N. Fusco
Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
2023 M. Ivanova, L. Bottiglieri, E. Sajjadi, K. Venetis, N. Fusco
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
2023 F.M. Porta, E. Sajjadi, K. Venetis, C. Frascarelli, G. Cursano, E. Guerini-Rocco, N. Fusco, M. Ivanova
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
2023 S. Morganti, A. Marra, S. Gandini, L. Ascione, M. Ivanova, K. Venetis, E. Sajjadi, P. Zagami, F. Giugliano, B. Taurelli Salimbeni, P.P.M. Berton Giachetti, C. Corti, E. De Camilli, G. Curigliano, N. Fusco, C. Criscitiello
Computational pathology to improve biomarker testing in breast cancer: how close are we?
2023 E. Sajjadi, C. Frascarelli, K. Venetis, G. Bonizzi, M. Ivanova, G. Vago, E. Guerini-Rocco, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Trop-2 as an Actionable Biomarker in Breast Cancer
2023 G. Cursano, E. Frigo, E. Sajjadi, M. Ivanova, K. Venetis, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
2023 E. Sajjadi, E. Guerini-Rocco, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, M. Ivanova, N. Fusco
HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations
2023 M. Ivanova, E. Sajjadi, L. Zattoni, N. Fusco
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022 G. Corso, O. D'Ecclesiis, F. Magnoni, E. Mazzotta, F. Conforti, P. Veronesi, E. Sajjadi, K. Venetis, N. Fusco, S. Gandini
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
2022 E. Sajjadi, K. Venetis, M. Noale, H.A. Azim, C. Blundo, G. Bonizzi, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, M. Barberis, P. Veronesi, V.E. Galimberti, G. Viale, N. Fusco, F.A. Peccatori, E. Guerini-Rocco